SLC26A11

Across TCGA pan-cancer cohorts, SLC26A11 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SLC26A11 data layer compared with 26 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher SLC26A11 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SLC26A11 expression acts as an unfavorable survival marker.

READ and SKCM are the cancer types where SLC26A11 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	II,III,IV	0.054	0.934	<.001	15	view →
SKCM	OS	Median	III,IV	0.216	0.721	.001	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SLC26A11–READ (OS)

Open the READ breakdown →